Login

Financial Snapshot

Revenue
TTM
$9.610M
Gross Margin
TTM
20.24%
Net Income
TTM
-$15.15M
Current Assets
2024 Q1
Current Liabilities
2024 Q1
Current Ratio
2024 Q1
52.4%
Total Assets
2024 Q1
Total Liabilities
2024 Q1
Book Value
2024 Q1
-$1.087M
Cash
2024 Q1
P/E
Last 4 Quarters
N/A
Free Cash Flow
TTM
-$4.591M

Stock Price

Loading...
Market Cap: $9.509 Thousand

About ThermoGenesis Holdings, Inc.

ThermoGenesis Holdings, Inc. engages in the research, development, commercialization, and marketing of automated cell processing technologies for the cell and gene therapy field. The company is headquartered in Rancho Cordova, California and currently employs 25 full-time employees. The firm provides the AutoXpress and BioArchive platforms for automated clinical bio-banking, the PXP platform for point-of-care cell-based therapies and X-Series products for cell processing services. Its product lines include Clinical Bio-Banking Applications, Point-of-Care Applications and Cell Processing. Its Clinical Bio-Banking Applications include AXP II Automated Cell Separation System and BioArchive Automated Cryopreservation System. Its Point-of-Care Applications include PXP Point-of-Care System, and PXP-1000 System. Its Cell Processing includes X-Series Products for general laboratory use: X-Lab for cell isolation, X-Wash System for cell washing and reformulation, and X-Mini for high efficiency small scale cell purification. The firm markets and sells its medical device products through independent distributors.

Industry: Laboratory Apparatus & Furniture Peers: Abbott Laboratories Advanced Biomedical Technologies Inc. ALLIED HEALTHCARE PRODUCTS INC Nuwellis Inc CYduct Diagnostics, Inc. INVIVO THERAPEUTICS HOLDINGS CORP. ENCISION INC Intelligent Bio Solutions Inc

Create Account

Sign up for free to unlock this feature.

Already have an account? Sign in

Premium Feature

This feature requires a premium subscription to unlock unlimited historical data and advanced analysis tools.

Premium includes:

  • Unlimited historical financial data
  • Advanced analytics and insights
  • Priority support